Price to Free Cash Flow of Pacira BioSciences Inc. PCRX is 41.10

Price to free cash flow is an equity valuation metric used to compare a company's per-share market price to its per-share amount of free cash flow (FCF). This metric is very similar to the valuation metric of price to cash flow but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CAPEX) from a company's total operating cash flow, thereby reflecting the actual cash flow available to fund non-asset-related growth. Companies use this metric when they need to expand their asset bases either in order to grow their businesses or simply to maintain acceptable levels of free cash flow. Because price to free cash flow is a value metric, lower numbers generally indicate that a company is undervalued and its stock is relatively cheap in relation to its free cash flow. Conversely, higher price to free cash flow numbers may indicate that the company's stock is relatively overvalued in relation to its free cash flow. Therefore, value investors favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.


Source: Investopedia

Price to Free Cash Flow
Jul 18Aug 18Sep 18Oct 18Nov 18Dec 18Jan 19Feb 19Mar 19Apr 19May 19Jun 19
-67.80-226.60-230.10-246.4035.7 thousand162.40142.90105.00113.1039.2045.8041.10